Evidence map›Paper›PMID 30169514›Full record

ArticlePloS one2018

Identifying the morphologic basis for radiomic features in distinguishing different Gleason grades of prostate cancer on MRI: Preliminary findings.

Gregory Penzias, Asha Singanamalli, Robin Elliott, Jay Gollamudi, Natalie Shih, Michael Feldman, Phillip D Stricker, Warick Delprado, Sarita Tiwari, Maret Böhm and 6 more

Abstract read
In one paragraph

Article in PloS one, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Article
  6. Article
  7. Article
  8. Deep learning prediction of stroke thrombus red blood cell content from multiparametric MRI.Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences · 2024
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Integrating pathomics with radiomics and genomics for cancer prognosis: A brief review.Chinese journal of cancer research = Chung-kuo yen cheng yen chiu · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Gregory PenziasDepartment of Biomedical Engineering, Case Western Reserve University, Cleveland, OH, United States of America.ORCID 0000-0002-5408-6810
Asha SinganamalliDepartment of Biomedical Engineering, Case Western Reserve University, Cleveland, OH, United States of America.
Robin ElliottUniversity Hospitals, Cleveland, OH, United States of America.
Jay GollamudiUniversity Hospitals, Cleveland, OH, United States of America.
Natalie ShihDepartment of Pathology, University of Pennsylvania, Philadelphia, PA, United States of America.
Michael FeldmanDepartment of Pathology, University of Pennsylvania, Philadelphia, PA, United States of America.
Phillip D StrickerSt. Vincent's Prostate Cancer Clinic, Darlinghurst, NSW, Australia.
Warick DelpradoDouglass Hanly Moir Pathology, Macquarie Park, NSW, Australia.
Sarita TiwariGarvan Institute of Medical Research/The Kinghorn Cancer Centre, Darlinghurst, NSW, Australia.
Maret BöhmGarvan Institute of Medical Research/The Kinghorn Cancer Centre, Darlinghurst, NSW, Australia.
Anne-Maree HaynesGarvan Institute of Medical Research/The Kinghorn Cancer Centre, Darlinghurst, NSW, Australia.
Lee PonskyUniversity Hospitals, Cleveland, OH, United States of America.
Pingfu FuDepartment of Population and Quantitative Health Sciences, Case Western Reserve University, Cleveland, OH, United States of America.
Pallavi TiwariDepartment of Biomedical Engineering, Case Western Reserve University, Cleveland, OH, United States of America.
Satish ViswanathDepartment of Biomedical Engineering, Case Western Reserve University, Cleveland, OH, United States of America.
Anant MadabhushiDepartment of Biomedical Engineering, Case Western Reserve University, Cleveland, OH, United States of America.

Funding

Computerized histologic image predictor of cancer outcomeR01CA202752 · NCI · CASE WESTERN RESERVE UNIVERSITY · PI FELDMAN, MICHAEL D, GANESAN, SHRIDAR · 2016 to 2020
$3.1M
Quantitative Histomorphometric Risk Classifier (QuHbIC) in HPV + Oropharyngeal CarcinomaR01CA220581 · NCI · CASE WESTERN RESERVE UNIVERSITY · PI KOYFMAN, SHLOMO, LEWIS, JAMES · 2018 to 2023
$3.1M
Computerized Histologic Risk Predictor (CHiRP) for Early Stage Lung CancersR01CA216579 · NCI · EMORY UNIVERSITY · PI FU, PINGFU, LLOYD, MARK · 2018 to 2023
$3.1M
MR Fingerprinting and Computerized Decision Support for Prostate CancerR01CA208236 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI GULANI, VIKAS, PONSKY, LEE EVAN · 2017 to 2022
$3.0M
Pathology Image Informatics Platform for visualization, analysis and managementU24CA199374 · NCI · CASE WESTERN RESERVE UNIVERSITY · PI GURCAN, METIN NAFI, MADABHUSHI, ANANT · 2015 to 2019
$2.9M
Comprehensive quantitative ultrafast 3D liver MRIR01DK098503 · NIDDK · CASE WESTERN RESERVE UNIVERSITY · PI GULANI, VIKAS, SEIBERLICH, NICOLE · 2013 to 2017
$2.6M
Histologic image-based aggressiveness prediction in p16+ oropharyngeal carcinomaR21CA179327 · NCI · CASE WESTERN RESERVE UNIVERSITY · PI MADABHUSHI, ANANT · 2014 to 2015
$389k
Computerized morphologic-molecular predictor of progression in DCISR21CA195152 · NCI · CASE WESTERN RESERVE UNIVERSITY · PI BADVE, SUNIL S., MADABHUSHI, ANANT · 2015 to 2016
$388k
BIOMEDICAL ENGINEERING RESEARCH FACILITIESC06RR012463 · NCRR · CASE WESTERN RESERVE UNIVERSITY · PI KUTINA, KENNETH L · 1997 to 1997
–
NCI NIH HHS R01 CA202752NCI NIH HHS R01 CA208236NCI NIH HHS R01 CA216579NCI NIH HHS R01 CA220581NCI NIH HHS R21 CA179327NCI NIH HHS R21 CA195152NCI NIH HHS U24 CA199374NCRR NIH HHS C06 RR012463NIDDK NIH HHS R01 DK098503
6 · The paper itself

Abstract

Translation of radiomics into the clinic may require a more comprehensive understanding of the underlying morphologic tissue characteristics they reflect. In the context of prostate cancer (PCa), some studies have correlated gross histological measurements of gland lumen, epithelium, and nuclei with disease appearance on MRI. Quantitative histomorphometry (QH), like radiomics for radiologic images, is the computer based extraction of features for describing tumor morphology on digitized tissue images. In this work, we attempt to establish the histomorphometric basis for radiomic features for prostate cancer by (1) identifying the radiomic features from T2w MRI most discriminating of low vs. intermediate/high Gleason score, (2) identifying QH features correlated with the most discriminating radiomic features previously identified, and (3) evaluating the discriminative ability of QH features found to be correlated with spatially co-localized radiomic features. On a cohort of 36 patients (23 for training, 13 for validation), Gabor texture features were identified as being most predictive of Gleason grade on MRI (AUC of 0.69) and gland lumen shape features were identified as the most predictive QH features (AUC = 0.75). Our results suggest that the PCa grade discriminability of Gabor features is a consequence of variations in gland shape and morphology at the tissue level.

Indexed as

HumansImage Interpretation, Computer-AssistedMagnetic Resonance ImagingMaleNeoplasm GradingProstatic NeoplasmsReproducibility of ResultsRetrospective StudiesROC Curve

Identifiers

PMID30169514
PMCPMC6118356

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.